Valtecne SpA

Valtecne SpA PEG

The PEG Ratio (Price/Earnings-to-Growth) of Valtecne SpA (VLT.MI) as of Oct 23, 2026 is 0.95. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.99 — a change of -3.80% (lower).

PEG

0.95

YoY

-3.80%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Valtecne SpA is 2025 0.95 . PEG Ratio (Price/Earnings-to-Growth) of Valtecne SpA was 2024 0.99 . It decreases by -3.80% lower compared to the previous year.

The Valtecne SpA PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2019
1.84 EUR
Jan 1, 2020
4.24 EUR
Jan 1, 2021
2.00 EUR
Jan 1, 2022
1.46 EUR
Jan 1, 2023
1.06 EUR
Jan 1, 2024
0.99 EUR
Jan 1, 2025
0.95 EUR
The Valtecne SpA PEG history
YEARPEGYoY
0.95-3.80%
0.99-6.92%
1.06-27.70%
1.46-26.87%
2.00-52.71%
4.24+130.49%
1.84—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valtecne SpA Stock analysis

What does Valtecne SpA do? Valtecne SpA produces precision-machined mechanical components for orthopedic and veterinary surgery, including cutting guides, pin pliers, femoral sizers, and tibial resection guides. The company also manufactures implantable devices such as femoral stems, femoral heads, stem collars, and tibial implants. These products are sold globally to medical device manufacturers and healthcare providers specializing in orthopedic and veterinary care. Valtecne SpA generates revenue through the sale of these high-precision surgical instruments and implantable devices to international medical markets. The company operates in the precision-machined sector, focusing on specialized instruments for orthopedic and veterinary surgery. Its product range includes both surgical tools like cutting guides and implantable components such as femoral stems. Valtecne SpA's global operations ensure its products reach medical device companies and clinics worldwide, supporting the production of advanced surgical solutions. Valtecne SpA's revenue model is based on manufacturing and selling precision-machined components for medical applications. The company's key products are surgical instruments and implantable devices used in orthopedic and veterinary procedures. By targeting medical device manufacturers and healthcare providers, Valtecne SpA secures contracts for its high-precision components, which are essential for surgical procedures and patient care. Valtecne SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valtecne SpA stock

PEG Ratio (Price/Earnings-to-Growth) of Valtecne SpA is 0.95 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Valtecne SpA changed from 0.99 to 0.95, representing a -3.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Valtecne SpA since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Valtecne SpA with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Valtecne SpA

All Key Metrics — Valtecne SpA